Brainomix Selected for UK Future Fifty Programme

Sep 20, 2026
Brainomix has been selected for Future Fifty, an invitation only programme for growing UK technology companies.

Brainomix was selected for the UK Future Fifty programme, the company said in a press release. The invitation only programme is delivered by Tech Nation and Founders Forum Group.

Brainomix joins a cohort of 25 companies spanning AI, health technology, biotechnology, financial technology, energy and advanced manufacturing. The cohort companies have raised a combined £1.47 billion and employ more than 3,800 people.

The University of Oxford spinout develops AI powered medical imaging software for stroke and lung disease. Its Brainomix 360 Stroke and Brainomix 360 e Lung platforms are used across health systems in more than 20 countries. Brainomix has secured £49 million in private and public funding and received more than 30 regulatory clearances.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.